OnKure Therapeutics, Inc. OKUR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s total equity?
- OnKure Therapeutics, Inc. (OKUR) reported total equity of $184.35M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s total equity changed year-over-year?
- OnKure Therapeutics, Inc.'s total equity increased by 103.4% year-over-year, from $90.65M to $184.35M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s total equity has grown at a 5.9% compound annual growth rate (CAGR), from -$42.12M to $56.18M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.